Methods of reducing neuroinflammation or toxicity induced by amyloid beta (abeta) using glucocorticoid induced leucine zipper (GILZ) analog peptides

Compositions and methods for increasing plant growth and improving multiple yield-related traits

Transdermal peptide with nuclear localization ability and use thereof

HETEROLOGOUS COMBINATION PRIME:BOOST THERAPY AND METHODS OF TREATMENT

Method for the preparation of low molecular weight porcine lympho-reticular polypeptides

SYSTEM AND METHOD FOR INDUCING CLUSTERS OF GENE REGULATORY PROTEINS TARGETED TO SPECIFIC GENOMIC LOCI

VIRAL VECTORS FOR THE TREATMENT OF RETINAL DYSTROPHY

ASPROSIN, A FAST-INDUCED GLUCOGENIC PROTEIN HORMONE

Materials and methods for treating Friedreich's Ataxia

Gram-negative lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof in human serum

Methods and systems for solid phase peptide synthesis

Bi-specific fusion proteins

Peptide ligase-mediated engineering of recombinant nucleosomes

Cyclic peptidyl inhibitors of CAL-PDZ binding domain

H3.3 CTL peptides and uses thereof

Cancer Antigen Peptide

Mutant NGAL proteins and uses thereof

Insoluble fusion protein comprising antimicrobial peptide and method for producing antimicrobial peptide using same

MODULATION OF P62 AND STING ACTIVITY

COMPOSITIONS AND METHODS FOR DETERMINING GENETIC POLYMORPHISMS IN THE TMEM216 GENE

RNA preparations comprising purified modified RNA for reprogramming cells

Target recognition motifs and uses thereof

MUTANT HSP70i TO PREVENT AUTOIMMUNE DISEASE

PRO-COAGULANT HISTONES

Disruption of the WAVE3 protein complex for suppression of invasion and metastasis

Therapeutic Agent for Psoriasis

MODIFIED HEAT SHOCK PROTEINS

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

Peptides and related compositions and methods

Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereof

COLON DISEASE TARGETS AND USES THEREOF

Composition and method for inhibiting amyloid β accumulation and/or aggregation

PEPTIDES DERIVED FROM P ANTIGEN FAMILY MEMBER 2 (PAGE2)

Micropeptides and uses thereof

Methods and compositions for treating alcoholic liver disease

MULTIVALENT HETEROMULTIMER SCAFFOLD DESIGN AND CONSTRUCTS

SOLUBLE FGFR3 DECOYS FOR TREATING SKELETAL GROWTH DISORDERS

C-terminal CDNF and MANF fragments, pharmaceutical compositions comprising same and uses thereof

Secretory protein

Chimeric inhibitor molecules of complement activation

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

Peptides with anti-cancer activity

Marker sequences for diagnosing and stratifying systemic sclerosis patients

Methods for manufacturing T cells by direct sorting and compositions thereof

Targeting deregulated Wnt signaling in cancer using stabilized alpha-helices of BCL-9

Structure-based peptide inhibitors of α-synuclein aggregation

DIAGNOSTIC FOR SJORGREN'S SYNDROME BASED ON A BIOMARKER

NOVEL COMPLEXES OF TYPES OF MHC CLASS II THAT BIND TO COLLAGEN TYPE II PEPTIDES AND THEIR USE ON DIAGNOSIS AND TREATMENT

HMGN partial peptide and cancer therapy using the same

IRS MODULATORS

Biomarkers for the early detection of breast cancer

METHODS OF USE OF SOLUBLE CD24 FOR THERAPY OF RHEUMATOID ARTHRITIS

Curcumin-peptide conjugates and formulations thereof

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

METHODS AND COMPOSITIONS FOR PROMOTING OPC DIFFERENTIATION AND REMYELINATION USING RECEPTOR ASSOCIATED PROTEIN (RAP)

Human-derived anti-huntingtin (HTT) antibodies and uses thereof

FUSION PROTEIN

Antibody-Mediated Transduction Of Heat Shock Proteins Into Living Cells

MODIFIED FRIEDREICH ATAXIA GENES AND VECTORS FOR GENE THERAPY

SORTING WITH COUNTER SELECTION USING SEQUENCE SIMILAR PEPTIDES

FRATAXIN-SENSITIVE MARKERS FOR DETERMINING EFFECTIVENESS OF FRATAXIN REPLACEMENT THERAPY

Specific-binding polypeptides and uses thereof

Histone anti-cancer vaccines

USE OF CEREBROLYSIN

TREATMENT OF SPINAL MUSCULAR ATROPHY

HIGH PRODUCTIVITY METHODS FOR GROWING ALGAE

HISTAMINE-RELEASING FACTOR (HRF), HRF-RECEPTOR AND METHODS OF MODULATING INFLAMMATION

SERUM AMYLOID P DERIVATIVES AND THEIR PREPARATION AND USE

Chimeric peptides with an antimicrobial domain and an inorganic binding domain

Vault complexes for cytokine delivery

Methods and compositions for preventing or treating cancer

Methods of Detecting Alloantibodies Using HLA and Non-HLA Antigens

Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics

Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases

Glycan-binding proteins and related compositions and methods

MONOCLONAL ANTIBODY FOR PREDICTING TAMOXIFEN RESPONSE IN BREAST CANCER PATIENTS

NEUTRALIZING ANTIBODIES AND METHODS OF USE THEREOF

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF SECRETED PROTEINS

METHOD OF TREATING A METABOLIC DISORDER OF THE LIVER

NON-NATURALLY OCCURRING CAPSIDS FOR DELIVERY OF NUCLEIC ACIDS AND/OR PROTEINS

Recombinant hypoallergenic Equ c 1 polypeptides for use in the immunotherapy of horse allergy

Immunotherapy against neuronal and brain tumors

Pair of amino acid sequences for monitoring formation of TDP-43 oligomer in living cells via bimolecular fluorescence complementation

Fibronectin binding domains with reduced immunogenicity

Peptide analogs

COMPOSITIONS AND METHODS FOR ENHANCING VISUAL FUNCTION

Nanocarriers having surface conjugated peptides and uses thereof for sustained local release of drugs

BTNL9 and ERMAP as novel inhibitors of the immune system for immunotherapies

Reducing beta-catenin and IDO expression to potentiate immunotherapy

Modified cascade ribonucleoproteins and uses thereof

Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor

Tumor-selective CTLA-4 antagonists

Peptides and combination of peptides for use in immunotherapy against various tumors

Modification and Compositions of Human Secretoglobin Proteins

COLON DISEASE TARGETS AND USES THEREOF

Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

Transthyretin immunoglobulin fusions

Immunogenic peptides and their use in immune disorders

Recombinant polypeptides derived from FBP1 and FBP2 and uses of the same

BIOMARKERS FOR COGNITIVE DYSFUNCTION DISEASES AND METHOD FOR DETECTING COGNITIVE DYSFUNCTION DISEASE USING BIOMARKERS

NEW ONCO-IMMUNOLOGIC PROGNOSTIC AND THERANOSTIC MARKERS

Ornithine transcarbamylase coding polyribonucleotides and formulations thereof

Gene therapies for lysosomal disorders

Peptides and combination of peptides for use in immunotherapy against various tumors

GENETICALLY ENCODED FLUORESCENT-IRON FERRITIN NANOPARTICLE PROBES FOR DETECTING AN INTRACELLULAR TARGET BY FLUORESCENT AND ELECTRON MICROSCOPY

Heterodimeric proteins for modulating gamma delta T cells

Muteins of human lipocalin 2 (Lcn2, hNGAL) with affinity for a given target

Stapled intracellular-targeting antimicrobial peptides to treat infection

Compositions containing HC-HA/PTX3 complexes and methods of use thereof

Gene therapy for neurometabolic disorders

Fusion proteins and methods thereof

NTRK1 fusion molecules and uses thereof

Programmable immunocyte receptor complex system

Cell-permeable bone morphogenetic protein (CPBMP) recombinant protein and use thereof

C-peptides and proinsulin polypeptides comprising the same

UBIQUITIN VARIANT MODULATORS OF SCF E3 LIGASES AND THEIR USES

POLYPEPTIDES AND USES THEREOF FOR THE TREATMENT OF CANCER

DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9

Targeted expansion of Qa-1-peptide-specific regulatory CD8 T cells to ameliorate arthritis

Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same

USE OF LINGO-4 ANTAGONISTS IN THE TREATMENT OF CONDITIONS INVOLVING DEMYELINATION

ECTODERMAL MESENCHYMAL STEM CELLS AND METHOD FOR PRODUCING SAME

METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN

NOVEL RECEPTORS FOR CYCLIC DINUCLEOTIDES AND METHODS AND KITS FOR SCREENING AGONISTS OR INHIBITORS THEREOF

BRCA2-mediated purification of recombinase protein

ENGINEERING STRUCTURALLY DEFINED NON-SACCHARIDE GLYCOSAMINOGLYCAN MIMETICS VIA A POLYPROLINE SCAFFOLD

Method of making recombinant silk and silk-amyloid hybrid proteins using bacteria

Method of producing a novel animal model for tauopathies

Protein binding to fibronectin B domain

Gene therapies for lysosomal disorders

IMPORTATION OF MITOCHONDRIAL PROTEIN BY AN ENHANCED ALLOTOPIC APPROACH

Citrullinated peptides that bind to types of MHC class II and their use on diagnosis and treatment

UBIQUITIN VARIANT MODULATORS OF HECT E3 LIGASES AND THEIR USES

Gene therapies for lysosomal disorders

METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES

Methods of identifying a moldulator of otopetrin-mediated proton translocation activity

MECP2E1 GENE

MECP2E1 GENE

WNT COMPOSITIONS AND METHODS FOR SERUM-FREE SYNTHESIS

Coiled coil immunoglobulin fusion proteins and compositions thereof

Polypeptides with phase transition, triblock polypeptides of the polypeptide-calmodulin-polypeptide with multi-stimuli responsiveness, hydrogel of the triblock polypeptides, and its uses

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml)

RESCUE OF CENTRAL AND PERIPHERAL NEUROLOGICAL PHENOTYPE OF FRIEDREICH'S ATAXIA BY INTRAVENOUS DELIVERY

Succinate-binding polypeptides and use thereof

Compositions and methods of use for recombinant human secretoglobins

Long-acting G-CSF for preventing neutropenia or reducing duration of neutropenia

Therapeutic DLL4 Binding Proteins

Vault particles having a modified R8 flexible region

A Cell-Based Seeding Assay for Huntingtin Aggregation

Compositions and methods for inhibition of L-plastin activity in osteoclasts to reduce bone loss

PROTEIN SECRETORY FACTOR WITH HIGH SECRETORY EFFICIENCY AND AN EXPRESSION VECTOR COMPRISING THE SAME

Optogenetic modulation by Multi-Characteristic Opsins for vision restoration and other applications

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of synucleinopathy

Kit for detecting coronary artery disease comprising an MAA protein adduct and reagents that bind to antibodies

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF ONCOLOGY-RELATED PROTEINS AND PEPTIDES

Methods and compositions employing immunogenic fusion proteins

Pharmaceutical composition for prevention or treatment of heart failure

Apelin peptides and uses thereof

COMPOUNDS AND METHODS OF MODULATING PROTEIN DEGRADATION

Artifical nucleases comprising engineered cleavage half-domains

Non-transgene transfection for therapeutic purposes

ACTIVATING MITOTIC CHECKPOINT CONTROL MECHANISMS

PRODUCTS AND METHODS ASSOCIATED WITH MULTIPLE SCLEROSIS AS A TRANSMISSIBLE PROTEIN MISFOLDING DISORDER

Validation of Neoepitope Presentation

Renal-homing peptide conjugates and methods of use thereof

LABELING AND DETECTION OF POST TRANSLATIONALLY MODIFIED PROTEINS

Materials and methods for extended continuous flow fermentation of reduced genome bacteria

Integrin Antagonists

Heterodimeric proteins for modulating gamma delta T cells

Peptides for treatment and prevention of hyperglycaemia

Compositions and methods for modulating immune cells

Methods and compositions for protein sequencing

Methods and compositions for protein sequencing

METHODS AND COMPOSITIONS FOR PROTEIN SEQUENCING

Methods and compositions for protein sequencing

Methods and compositions for protein sequencing

Methods for treating anemia in a subject in need thereof

Method of inhibiting apoptosis or promoting cell survival by providing a bi-specific protein comprising insulin-like growth factor IGF-1 and Annexin A5

Manipulation of EIF3 to modulate repeat associated non-ATG (RAN) translation

Allele-specific therapy for Huntington disease haplotypes

Methods for treating anemia in a subject in need thereof

Methods for treating anemia in a subject in need thereof

ISOLATED GDF TRAP POLYPEPTIDE

WNT SIGNALING AGONIST MOLECULES

WNT SIGNALING AGONIST MOLECULES

Methods and compositions for regenerating tissues

Compositions and methods for targeting nuclear import shuttles and treating inflammatory disorders

Peptide, complex of peptide and siRNA, and methods of use thereof

Circular tandem repeat proteins

Fusion protein of DCTN1 protein with RET protein

CONSTITUTIVELY ACTIVE PROFILIN-1 FOR USE IN THE THERAPY AND/OR TREATMENT OF A NEUROLOGICAL DISORDER AND/OR FOR PROMOTING NEURONAL REGENERATION, KIT AND PRODUCTS THEREOF

DNA vaccine against virus of Yellow Fever

Mouse with cholinergic neuron-specific inactivated ANO1 gene

Humanized anti-PACAP antibodies

Humanized anti-PACAP antibodies

ENGINEERED T-CELL MODULATING MOLECULES AND METHODS OF USING SAME

Recombinant klotho proteins and compositions and methods involving same

Therapeutic peptides

MUC1-derived peptide, and pharmaceutical composition for treatment or prevention of cancer, immunity-inducing agent and method for manufacturing antigen presenting cell using same

Nucleotide, polypeptide and applications thereof

Fusion proteins and methods thereof

Small Molecule Sensitization of BAX Activation for Induction of Cell Death

ISOLATED GDF TRAP POLYPEPTIDE

Humanized anti-PACAP antibodies

NETRIN- 1 AND DEPENDENCE RECEPTOR PROTEINS AND METHOD OF USE

Methods and reagents for treatment of age-related macular degeneration

COMPOSITIONS AND METHODS FOR EXPRESSING OTOFERLIN

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE

Heterocyclic compound

Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins

Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems

Genetic engineering of macrophages for immunotherapy

Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions

HLA-G transcripts and isoforms and their uses

Antitumor peptide and use thereof

NOVEL INTERLEUKIN-17A-SPECIFIC AND INTERLEUKIN-23-SPECIFIC BINDING POLYPEPTIDES AND USES THEREOF

Small molecules blocking histone reader domains

Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins and its application thereof

Regulation of RAN translation by PKR and eIF2A-P pathways

Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload

Nucleic acid molecules encoding human neutrophil gelatinase-associated lipocalin (hNGAL) which bind angiopoietin-2 (Ang-2)

Nanoscale drug carrier capable of passing through blood-brain barrier

VEGF antagonist formulations suitable for intravitreal administration

Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity by UPF1

Versatile display scaffolds for proteins

Biocatalysts for Ezetimibe synthesis

Fibronectin binding domains with reduced immunogenicity

Therapy for subarachnoid hemorrhage and ischemia

Human IgE antibodies binding to aspergillus allergens

Method for diagnosing or treating pulmonary fibrosis using S100A13 protein

Extracellular vesicle comprising a fusion protein having Fc binding capacity

Antiviral peptide and use thereof

METHODS AND COMPOSITIONS RELATED TO RECOMBINANT NEIL2

Methods for treatment of nephrotic syndrome and related conditions

H3.3 CTL peptides and uses thereof

METHOD FOR TREATING AN AUDITORY NEUROPATHY SPECTRUM DISORDER

Methods of treating cancer having an active Wnt/β-catenin pathway

Functionalization of biopolymers with growth factor-binding peptides

USE OF PEPTIDES AS BIOMARKERS IN THE DIAGNOSIS, CONFIRMATION AND TREATMENT OF A NEUROLOGICAL DISORDER AND TCR AND/OR HLA IMMUNOPROFILING IN NEURODEGENERATIVE DISEASE

Methods and compositions for rapidly replacing cardiac myosin binding protein-C in sarcomeres

RNA-binding protein

Peptides and combination of peptides for use in immunotherapy against various cancers

Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML)

Relaxin1 derived peptides for use in immunotherapy

PNEUMOCOCCAL FUSION PROTEIN VACCINES

POLYPEPTIDE-POLYMER CONJUGATES AND METHODS OF USE THEREOF

Adiponectin peptidomimetics for treating ocular disorders

Peptides and compositions for treatment of joint damage

CONJUGATE WITH ATTENUATED IMMUNE RESPONSE

Biomarker pairs for predicting preterm birth

Gene therapies for lysosomal disorders

Method for the treatment or prevention of a disease related to vascular endothelial lipase by administering a humanized monoclonal antibody

TGF-BETA SUPERFAMILY HETEROMULTIMERS AND USES THEREOF

Synthetic protein circuits detecting signal transducer activity

In vitro production of red blood cells with proteins comprising sortase recognition motifs

METHOD FOR COVALENT BOND MODIFYING MAMMALIAN ATG8 HOMOLOGUE

Specific GNAI:GIV interaction screening assays, methods and compositions

Activatable antibodies and methods of use thereof

Ca2+ regulated binding agents

Cell-Permeable Peptide Inhibitors of the JNK Signal Transduction Pathway

Gene therapy for ocular disorders

Biomarker for mental disorders including cognitive disorders, and method using said biomarker to detect mental disorders including cognitive disorders

CRISPR-BASED TREATMENT OF FRIEDREICH ATAXIA

Compositions useful in treatment of spinal muscular atrophy

Minigene therapy

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

Bi-specific fusion proteins

NOVEL USE OF REGULATORY T CELL-SPECIFIC SURFACE PROTEIN LRIG-1

Tissue-specific Wnt signal enhancing molecules and uses thereof

Human tear lipocalin muteins which specifically bind lymphocyte activation gene-3 (LAG3) and method of use thereof to stimulate an immune response

Protoxin-II variants and methods of use

Fused cyclooctyne compounds and their use in metal-free click reactions

Transdermal optogenetic peripheral nerve stimulation

Modified cascade ribonucleoproteins and uses thereof

Peptides and combination of peptides for use in immunotherapy against various tumors

Interaction of Draxin and γ-netrins

Epitope tag and method for detection and/or purification of tagged polypeptides

Tuning of release kinetics in hydrogels

Fusion proteins and methods thereof

Peptides and uses thereof for diagnosing and treating myasthenia gravis

Pumilio domain-based modular protein architecture for RNA binding

NUCLEOPHOSMIN PROTEIN (NPM) MUTANTS, CORRESPONDING GENE SEQUENCES AND USES THEREOF

Methods and compositions for the treatment of cancer or other diseases

Antitumor peptide and use thereof

Peptides and combination of peptides for use in immunotherapy against various tumors

RNA containing modified nucleosides and methods of use thereof

ENGINEERED LIGHT-ACTIVATED ANION CHANNEL PROTEINS AND METHODS OF USE THEREOF

Methods and compositions for vault nanoparticle immobilization of therapeutic molecules and for vault targeting

Peptides and combination of peptides for use in immunotherapy against various tumors

Isolated B7-H4 specific compositions and methods of use thereof

Non-meiotic allele introgression

Non-meiotic allele introgression

Anti-TrkB agonist antibodies binding to D5 domain of TrkB and methods of promoting neuronal survival in motor neuron injury, stroke or glaucoma

VEGF antagonist formulations suitable for intravitreal administration

Modified polynucleotides for the production of secreted proteins

Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment

CCN3 and CCN3 peptides and analogs thereof for therapeutic use

Recombinant protein UK 114 in stable polymer form for use in the treatment, diagnosis and prevention of malignant solid and systemic tumours

Methods, compounds and compositions for modulating blood brain barrier integrity and re-myelination